Dimethylformamide → Ammonia
Reaction equation
[CH3:1][O:2][C:3]1[C:17]([O:18][CH3:19])=[CH:16][C:6]2[NH:7][C:8]([C:10]3[C:14]([NH2:15])=[CH:13][NH:12][N:11]=3)=[N:9][C:5]=2[CH:4]=1.CN(C(ON1N=NC2C=[CH:32][CH:33]=[CH:34][C:29]1=2)=[N+](C)C)C.[B-](F)(F)(F)F.[OH-:42].[Na+].[CH3:44][N:45]([CH:47]=O)[CH3:46]>>[NH3:7].[CH3:19][O:18][C:17]1[C:3]([O:2][CH3:1])=[CH:4][C:5]2[NH:9][C:8]([C:10]3[C:14]([NH:15][C:32]([CH:33]4[CH2:34][CH2:29][CH2:46][N:45]([CH3:44])[CH2:47]4)=[O:42])=[CH:13][NH:12][N:11]=3)=[N:7][C:6]=2[CH:16]=1Participants
Procedure
To a solution of 3-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-ylamine (65 mg, 0.25 mmol) (Example 15B) (rac)-1-methyl-piperidine-3-carboxylic acid-hydrocholoride salt (50 mg, 0.27 mmol) and disopropylethylamine (50 μl, 0.27 mmol) in DMF (1 ml) was added TBTU (97 mg, 0.30 mmol). The mixture was stirred at room temperature for approximately 16 hours after which 1N aqueous NaOH (1 ml) was added and the mixture stirred for a further 1 hours. The mixture was then evaporated to dryness in vacuo and the residue purified by flash column chromatography (SiO2, eluting with a gradient of DCM:MeOH (98:2) to DCM: MeOH; conc. Aq. NH3 (70:30:3) to give N-[3-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-rac-1-methyl-piperidine 3-carboxamide (20 mg) as a colourless gum (LC/MS (basic method): Rt 2.35 min, (M+H)+ 385).
Workup
- additionwas added
- customThe mixture was then evaporated to dryness in vacuo
- customthe residue purified by flash column chromatography (SiO2
- washeluting with a gradient of DCM:MeOH (98:2) to DCM
Sources & evidence
- ORD record
- ord-d2bf815b03d2484a8e709584ef657998
- Source dataset
- uspto-grants-2013_03
- Patent number
- US08399442B2
Reaction notes
Loading…